Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Eric Olson
Ut Southwestern Medical Center, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Exonics Therapeutics
Reimbursed or sponsored travel
NA
Myoediting of Duchenne muscular dystrophy
The goal of the UT Southwestern MDCRC is to improve treatment of DMD by advancing a new and rapidly evolving technology that combines the CRISPR/Cas9 system of genomic editing with the ability to generate induced pluripotent stem cells (iPSCs). We have termed this process 'myoediting.'
Filed on April 27, 2017.
Tell us what you know about Eric Olson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Eric Olson filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Eric Olson | Ut Southwestern Medical Center | Conflict of Interest | Exonics Therapeutics | $60,000 - $79,999 |
| Eric Olson | Ut Southwestern Medical Center | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 |
| Eric Olson | Ut Southwestern Medical Center | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 |
| Eric Olson | Ut Southwestern Medical Center | Conflict of Interest | Exonics Therapeutics | $0 - $4,999 |
| Eric Olson | Ut Southwestern Medical Center | Conflict of Interest | miRagen Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.